Stroke in Women: Risk Factors and Clinical Biomarkers
The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
Stroke has been emerged as one of major health problems for women worldwide. Increasing of knowledge in this field has provided new data in this area which contribute to finding of new risk factors and could improve stroke treatment. A large number studies indicated a variety of risk factors including sex, age, race, smoking, diabetes, and physical inactivity could be involved in stroke in women. The understanding of various aspects involved in women stroke including risk factors, outcomes, stroke recovery, and prevention could provide new therapeutic platforms which could likely lead to better treatment in women stroke. Diagnosis is one of important steps in stroke therapy. It has been showed that a variety of biomarkers such as microRNAs (miRNAs), tPA, and von willebrand factor could be used as therapeutic and diagnostic biomarkers in stroke therapy. Here, we summarized various aspects of stroke in women which could help to recognition risk factors, outcomes, care, treatment, and novel biomarkers involve in treatment of stroke. J. Cell. Biochem. 118: 4191–4202, 2017. © 2017 Wiley Periodicals, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kernan, W. N., Ovbiagele, B., Black, H. R., Bravata, D. M., Chimowitz, M. I., Ezekowitz, M. D., Fang, M. C., Fisher, M., Furie, K. L., Heck, D. V., et al. (2014) · Stroke · doi:10.1161/str.0000000000000024 · Cited by 5,170 · cited 2×
“In addition, the symptoms associated with women are facial and limb pain; nausea; general weakness; chest pain; shortness of breath; palpitations; hiccups (56).”
BackgroundMethodObstructive Sleep Apnea as a Risk Factor for Stroke and Death
Yaggi, H. K., Concato, J., Kernan, W. N., Lichtman, J. H., Brass, L. M., & Mohsenin, V. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043104 · Cited by 3,004 · cited 1×
“For example, it found that miRNAs involved in depression after stroke and play significant roles in this occurrence [Yan et al., 2013].”
BackgroundFeigin, V. L., Lawes, C. M., Bennett, D. A., Barker-Collo, S. L., & Parag, V. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70025-0 · Cited by 2,855
Estrogen plus Progestin and the Risk of Coronary Heart Disease
Manson, J. E., Hsia, J., Johnson, K. C., Rossouw, J. E., Assaf, A. R., Lasser, N. L., Trevisan, M., Black, H. R., Heckbert, S. R., Detrano, R., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030808 · Cited by 2,065 · cited 5×
“In other studies, researchers showed that HRT may increase the risk of stroke and CHD [Manson et al., 2003; Wassertheil-Smoller et al., 2003; Hendrix et al., 2006).”
BackgroundResultInfluentialSex differences in stroke: epidemiology, clinical presentation, medical care, and outcomes
Reeves, M. J., Bushnell, C. D., Howard, G., Gargano, J. W., Duncan, P. W., Lynch, G., Khatiwoda, A., & Lisabeth, L. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70193-5 · Cited by 1,362
miR-124 regulates adult neurogenesis in the subventricular zone stem cell niche
Cheng, L.-C., Pastrana, E., Tavazoie, M., & Doetsch, F. (2009) · Nature Neuroscience · doi:10.1038/nn.2294 · Cited by 1,001 · cited 2×
“MiR-124 plays important roles such as adult neurogenesis and neuronal differentiation during CNS development [Yu et al., 2008; Cheng et al., 2009].”
BackgroundSudlow, C. L. M., & Warlow, C. P. (1997) · Stroke · doi:10.1161/01.str.28.3.491 · Cited by 885
Peters, S. A. E., Huxley, R. R., & Woodward, M. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60040-4 · Cited by 805
Gage, B. F., van Walraven, C., Pearce, L., Hart, R. G., Koudstaal, P. J., Boode, B. S. P., & Petersen, P. (2004) · Circulation · doi:10.1161/01.cir.0000145172.55640.93 · Cited by 749 · cited 2×
“The utilization of The CHADS2 scoring is one of important prognostic model for stroke treatment [Gage et al., 2004].”
MethodGender Differences in Stroke Incidence and Poststroke Disability in the Framingham Heart Study
Petrea, R. E., Beiser, A. S., Seshadri, S., Kelly-Hayes, M., Kase, C. S., & Wolf, P. A. (2009) · Stroke · doi:10.1161/strokeaha.108.542894 · Cited by 672 · cited 3×
“Some data on other stroke subtypes indicated that there are no significant difference between women and men [Petrea et al., 2009], whereas other reports revealed that men are more likely to presence with small vessel strokes and large vessel as well as intracerebral hemorrhage [Appelros et al.,…”
BackgroundResult
Cited by
Breast cancer diagnosis: Imaging techniques and biochemical markers
Jafari, S. H., Saadatpour, Z., Salmaninejad, A., Momeni, F., Mokhtari, M., Nahand, J. S., Rahmati, M., Mirzaei, H., & Kianmehr, M. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26379 · Cited by 410
Self-citationJiang, M., Wang, H., Jin, M., Yang, X., Ji, H., Jiang, Y., Zhang, H., Wu, F., Wu, G., Lai, X., et al. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000490078 · Cited by 305
MicroRNA: A novel target of curcumin in cancer therapy
Mirzaei, H., Masoudifar, A., Sahebkar, A., Zare, N., Sadri Nahand, J., Rashidi, B., Mehrabian, E., Mohammadi, M., Mirzaei, H. R., & Jaafari, M. R. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26055 · Cited by 236
Self-citationExosomes and microRNAs: New potential therapeutic candidates in Alzheimer disease therapy
Iranifar, E., Seresht, B. M., Momeni, F., Fadaei, E., Mehr, M. H., Ebrahimi, Z., Rahmati, M., Kharazinejad, E., & Mirzaei, H. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.27214 · Cited by 93
Self-citationMiRNA: Involvement of the MAPK Pathway in Ischemic Stroke. A Promising Therapeutic Target
Gugliandolo, A., Silvestro, S., Sindona, C., Bramanti, P., & Mazzon, E. (2021) · Medicina · doi:10.3390/medicina57101053 · Cited by 49
Metadata
- Authors
- Mirzaei, H.
- Venue
- Journal of Cellular Biochemistry
- Publisher
- Wiley
- Published
- 2017-06-13
- Volume
- 118
- Issue
- 12
- Pages
- 4191-4202
- ISSN
- 0730-2312 (ISSN-L)
- 1097-4644
- OpenAlex
- W2761397669
- Cited by
- 105
- References
- 21
- FWCI
- 12.43
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.